|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 November 2000, Vol. 96, No. 10, pp. 3431-3438
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Sphingosine 1-phosphate as a major bioactive lysophospholipid
that is released from platelets and interacts with endothelial
cells
Yutaka Yatomi,
Tsukasa Ohmori,
Ge Rile,
Fuminori Kazama,
Hirotaka Okamoto,
Takamitsu Sano,
Kaneo Satoh,
Shoji Kume,
Gabor Tigyi,
Yasuyuki Igarashi, and
Yukio Ozaki
From the Department of Laboratory Medicine, Yamanashi
Medical University, Nakakoma, Japan; the Department of Biomembrane and
Biofunctional Chemistry, Graduate School of Pharmaceutical Sciences,
Hokkaido University, Sapporo, Japan; and the Department of
Physiology, University of Tennessee Health Science Center, Memphis,
TN.
The serum-borne lysophospholipid mediators sphingosine 1-phosphate
(Sph-1-P) and lysophosphatidic acid (LPA) have been shown to be
released from activated platelets and to act on endothelial cells. In
this study, we employed the repeated lipid extraction (under alkaline
and acidic conditions), capable of detecting Sph-1-P, LPA, and possibly
structurally similar lysophospholipids, whereby a marked formation of
[32P]Sph-1-P, but not [32P]LPA, was
observed in [32P]orthophosphate-labeled platelets.
Platelet Sph-1-P release, possibly mediated by protein kinase C, was
greatly enhanced in the presence of albumin, which formed a complex
with Sph-1-P. This finding suggests that platelet Sph-1-P may become
accessible to depletion by albumin when its transbilayer movement
(flipping) across the plasma membrane is enhanced by protein kinase C. Although human umbilical vein endothelial cells expressed receptors for both Sph-1-P and LPA, Sph-1-P acted much more potently than LPA on the
cells in terms of intracellular Ca++ mobilization,
cytoskeletal reorganization, and migration. The results suggest that
Sph-1-P, rather than LPA, is a major bioactive lysophospholipid that is
released from platelets and interacts with endothelial cells, under the
conditions in which critical platelet-endothelial interactions
(including thrombosis, angiogenesis, and atherosclerosis) occur.
Furthermore, albumin-bound Sph-1-P may account for at least some of the
serum biological activities on endothelial cells, which have been
ascribed to the effects of albumin-bound LPA, based on the similarities
between LPA and serum effects.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Kobayashi, N. Kobayashi, A. Yamaguchi, and T. Nishi
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes
J. Biol. Chem.,
August 7, 2009;
284(32):
21192 - 21200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gossens, S. Naus, S. Y. Corbel, S. Lin, F. M.V. Rossi, J. Kast, and H. J. Ziltener
Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25
J. Exp. Med.,
April 13, 2009;
206(4):
761 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Bozza, A. M. Shah, A. S. Weyrich, and G. A. Zimmerman
Amicus or Adversary: Platelets in Lung Biology, Acute Injury, and Inflammation
Am. J. Respir. Cell Mol. Biol.,
February 1, 2009;
40(2):
123 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-C. Su, E. A. Mendoza, H.-i. Kwak, and K. J. Bayless
Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1215 - C1229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hosogaya, Y. Yatomi, K. Nakamura, R. Ohkawa, S. Okubo, H. Yokota, M. Ohta, H. Yamazaki, T. Koike, and Y. Ozaki
Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity
Ann Clin Biochem,
July 1, 2008;
45(4):
364 - 368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Park, C. Will, B. Martin, L. Gullotti, N. Friedrichs, R. Buettner, H. Schneider, S. Ludwig, and V. Wixler
Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins
FASEB J,
July 1, 2008;
22(7):
2508 - 2520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Holland and S. A. Summers
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
Endocr. Rev.,
June 1, 2008;
29(4):
381 - 402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Wixler, S. Hirner, J. M. Muller, L. Gullotti, C. Will, J. Kirfel, T. Gunther, H. Schneider, A. Bosserhoff, H. Schorle, et al.
Deficiency in the LIM-only protein Fhl2 impairs skin wound healing
J. Cell Biol.,
April 9, 2007;
177(1):
163 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Jung, J. S. Lee, Y. J. Kim, Y.-I. Jeong, C.-M. Lee, T. Baumruker, A. Billlich, Y. Banno, M. G. Lee, S.-C. Ahn, et al.
Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells
Int. Immunol.,
April 1, 2007;
19(4):
411 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wojciak-Stothard, L. Y. F. Tsang, E. Paleolog, S. M. Hall, and S. G. Haworth
Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
June 1, 2006;
290(6):
L1173 - L1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kobayashi, T. Nishi, T. Hirata, A. Kihara, T. Sano, Y. Igarashi, and A. Yamaguchi
Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner
J. Lipid Res.,
March 1, 2006;
47(3):
614 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev,
January 1, 2006;
86(1):
279 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sano, A. Kihara, F. Kurotsu, S. Iwaki, and Y. Igarashi
Regulation of the Sphingoid Long-chain Base Kinase Lcb4p by Ergosterol and Heme: STUDIES IN PHYTOSPHINGOSINE-RESISTANT MUTANTS
J. Biol. Chem.,
November 4, 2005;
280(44):
36674 - 36682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aoki, Y. Yatomi, M. Ohta, M. Osada, F. Kazama, K. Satoh, K. Nakahara, and Y. Ozaki
Sphingosine 1-Phosphate-Related Metabolism in the Blood Vessel
J. Biochem.,
July 1, 2005;
138(1):
47 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Limaye, X. Li, C. Hahn, P. Xia, M. C. Berndt, M. A. Vadas, and J. R. Gamble
Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members
Blood,
April 15, 2005;
105(8):
3169 - 3177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Summers and D. H. Nelson
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome
Diabetes,
March 1, 2005;
54(3):
591 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Krump-Konvalinkova, S. Yasuda, T. Rubic, N. Makarova, J. Mages, W. Erl, C. Vosseler, C. J. Kirkpatrick, G. Tigyi, and W. Siess
Stable Knock-Down of the Sphingosine 1-Phosphate Receptor S1P1 Influences Multiple Functions of Human Endothelial Cells
Arterioscler Thromb Vasc Biol,
March 1, 2005;
25(3):
546 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yatomi, S. Yamamura, N. Hisano, K. Nakahara, Y. Igarashi, and Y. Ozaki
Sphingosine 1-Phosphate Breakdown in Platelets
J. Biochem.,
October 1, 2004;
136(4):
495 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Roviezzo, F. Del Galdo, G. Abbate, M. Bucci, B. D'Agostino, E. Antunes, G. De Dominicis, L. Parente, F. Rossi, G. Cirino, et al.
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate
PNAS,
July 27, 2004;
101(30):
11170 - 11175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou and K. S. Murthy
Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2
Am J Physiol Cell Physiol,
May 1, 2004;
286(5):
C1130 - C1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Deguchi, S. Yegneswaran, and J. H. Griffin
Sphingolipids as Bioactive Regulators of Thrombin Generation
J. Biol. Chem.,
March 26, 2004;
279(13):
12036 - 12042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takeya, E. C. Gabazza, S. Aoki, H. Ueno, and K. Suzuki
Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells
Blood,
September 1, 2003;
102(5):
1693 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Kim, E. J. Jo, H.-Y. Lee, M. S. Cha, J. K. Min, C. H. Choi, Y. M. Lee, Y.-A. Choi, S.-H. Baek, S. H. Ryu, et al.
Sphingosine 1-Phosphate in Amniotic Fluid Modulates Cyclooxygenase-2 Expression in Human Amnion-derived WISH Cells
J. Biol. Chem.,
August 22, 2003;
278(34):
31731 - 31736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Schaphorst, E. Chiang, K. N. Jacobs, A. Zaiman, V. Natarajan, F. Wigley, and J. G. N. Garcia
Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products
Am J Physiol Lung Cell Mol Physiol,
July 1, 2003;
285(1):
L258 - L267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jin, E. Knudsen, L. Wang, Y. Bryceson, B. Damaj, S. Gessani, and A. A. Maghazachi
Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation
Blood,
June 15, 2003;
101(12):
4909 - 4915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sano, D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi
Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood
J. Biol. Chem.,
June 7, 2002;
277(24):
21197 - 21206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lum
Lysophospholipids in the regulation of endothelial barrier function
Am J Physiol Lung Cell Mol Physiol,
December 1, 2001;
281(6):
L1335 - L1336.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tosaka, F. Okajima, Y. Hashiba, N. Saito, T. Nagano, T. Watanabe, T. Kimura, and T. Sasaki
Sphingosine 1-Phosphate Contracts Canine Basilar Arteries In Vitro and In Vivo: Possible Role in Pathogenesis of Cerebral Vasospasm
Stroke,
December 1, 2001;
32(12):
2913 - 2919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre
Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology
Circ. Res.,
November 23, 2001;
89(11):
957 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Abnet, C. B. Borkowf, Y.-L. Qiao, P. S. Albert, E. Wang, A. H. Merrill Jr., S. D. Mark, Z.-W. Dong, P. R. Taylor, and S. M. Dawsey
A Cross-Sectional Study of Human Serum Sphingolipids, Diet and Physiologic Parameters
J. Nutr.,
October 1, 2001;
131(10):
2748 - 2752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kluk and T. Hla
Role of the Sphingosine 1-Phosphate Receptor EDG-1 in Vascular Smooth Muscle Cell Proliferation and Migration
Circ. Res.,
September 14, 2001;
89(6):
496 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|